Dwarkesh Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 32.93%
- Profit Growth 342.15%
- Ebitda 15.69%
- Net Worth 113.26%
- Total Assets 18.69%
About Dwarkesh Pharmaceutical
Dwarkesh Pharmaceutical Pvt Ltd (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 1995 and has a history of 29 years and four months. Its registered office is in Ahmedabad, Gujarat.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeshkumar Gupta, Rajat Gupta, and Anju Rajeshkumar serve as directors at the Company.
Company Details
-
LocationAhmedabad, Gujarat
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ1995PTC027524
-
Company No.
027524
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Dwarkesh Pharmaceutical Pvt Ltd offer?
Dwarkesh Pharmaceutical Pvt Ltd offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Child and Baby Care Products, Baby Care Products, Anti Inflammatory Drugs, Common Disease Medicines.
Who are the key members and board of directors at Dwarkesh Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshkumar Gupta
|
Whole-Time Director | 29-Sep-1995 | Current |
|
Rajat Gupta
|
Director | 12-Nov-2010 | Current |
|
Anju Rajeshkumar
|
Director | 25-Sep-2017 | Current |
Financial Performance of Dwarkesh Pharmaceutical.
Dwarkesh Pharmaceutical Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 32.93% increase. The company also saw a substantial improvement in profitability, with a 342.15% increase in profit. The company's net worth Soared by an impressive increase of 113.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dwarkesh Pharmaceutical?
In 2022, Dwarkesh Pharmaceutical had a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dwarkesh Pharmaceutical?
Unlock and access historical data on people associated with Dwarkesh Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dwarkesh Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dwarkesh Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
